GlassScriptPhysician profile
Robert Catana
NPI 1336183334
$4,654.80
in general payments reported to CMS, 2019-2025
20 companies · $98.02 in 2025
The $98.02 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,305 · 2020: $428 · 2021: $250 · 2022: $408 · 2023: $76.90 · 2024: $89.35 · 2025: $98.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,213.17 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Si-Bone, INC. | $464.75 | 2019-2021 | |
| Depuy Synthes Sales INC. | $341.24 | 2019-2022 | |
| Stryker Corporation | $129.37 | 2019-2025 | Inspace |
| Wright Medical Technology, INC. | $79.37 | 2019 | |
| Fx Shoulder Solutions, INC | $65.31 | 2022 | |
| Bioventus LLC | $60.47 | 2019-2023 | Supartz Fx Sodium Hyaluronate, L360 Thigh System |
| Pacira Therapeutics, INC. | $44.57 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $37.04 | 2023-2025 | Euflexxa |
| Amarin Pharma, INC. | $35.00 | 2019 | |
| Kerecis Limited | $31.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $22.85 | 2025 | Flector, Licart, Tirosint |
| Kowa Pharmaceuticals America, INC. | $19.35 | 2022 | |
| Organogenesis INC. | $18.23 | 2022 | |
| Sonex Health, INC. | $17.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $15.80 | 2021 | |
| Djo, LLC | $15.27 | 2021 | |
| Endo Pharmaceuticals INC. | $15.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.35 | 2024 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $13.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Catana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.